OAM
PTCT icon

OP Asset Management’s PTC Therapeutics PTCT Stock Holding History

OP Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$529K Sell
6,484
-27,118
-81% -$1.96M 0.01% 663
2026
Q1 		$2.29M Buy
33,602
+31,893
+1,866% +$2.26M 0.02% 423
2025
Q4 		$130K Hold
1,709
– – ﹤0.01% 744
2025
Q3 		$105K Sell
1,709
-9,614
-85% -$501K ﹤0.01% 756
2025
Q2 		$553K Buy
+11,323
New +$538K 0.01% 656

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

OP Asset Management's PTCT Position: Q2 2026 in Review

OP Asset Management reduced its PTC Therapeutics (PTCT) stake by 81% in Q2 2026, selling an estimated $1.96M and leaving 6,484 shares worth $529K. The position accounts for 0.01% of the portfolio, ranked #663.

OP Asset Management first reported a position in PTCT in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.29M in Q1 2026. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • OP Asset Management held 6,484 shares of PTC Therapeutics worth $529K as of Q2 2026.
  • OP Asset Management sold 27,118 PTC Therapeutics shares in Q2 2026, an estimated $1.96M.
  • PTC Therapeutics made up 0.01% of OP Asset Management's portfolio in Q2 2026, its #663 holding.
  • OP Asset Management first reported a position in PTC Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • OP Asset Management's PTC Therapeutics position peaked at $2.29M in Q1 2026.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.